Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers- bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/23/25 | $55,000,000 | Series B |
Balderton Capital Creandum firstminute.capital Seedcamp Visionaries Club | undisclosed |
